Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, announces a global research collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to discover and validate modulators of up to five therapeutic targets using its Microcycle® technology, initially for oncology and neurology indications.